Accuray Incorporated (0H8I.L)
USD 1.47
(2.4%)
USD 1.47
(2.4%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 138.32 Million USD | -4.7% |
| 2022 | 145.15 Million USD | 2.04% |
| 2021 | 142.25 Million USD | 12.96% |
| 2020 | 125.92 Million USD | -6.28% |
| 2019 | 134.37 Million USD | 11.22% |
| 2018 | 120.82 Million USD | 11.32% |
| 2017 | 108.54 Million USD | 3.32% |
| 2016 | 105.05 Million USD | -9.43% |
| 2015 | 115.98 Million USD | 9.27% |
| 2014 | 106.15 Million USD | 20.97% |
| 2013 | 87.75 Million USD | 7.55% |
| 2012 | 81.59 Million USD | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 FY | 138.32 Million USD | -4.7% |
| 2023 Q1 | 149.97 Million USD | 3.33% |
| 2023 Q2 | 155.22 Million USD | 3.5% |
| 2023 Q3 | 159.56 Million USD | 2.79% |
| 2023 Q4 | 138.32 Million USD | -13.31% |
| 2022 Q3 | 150.58 Million USD | -3.27% |
| 2022 Q4 | 145.15 Million USD | -3.61% |
| 2022 Q1 | 152.62 Million USD | 7.29% |
| 2022 Q2 | 155.66 Million USD | 1.99% |
| 2022 FY | 145.15 Million USD | 2.04% |
| 2021 Q3 | 137.51 Million USD | 11.19% |
| 2021 FY | 142.25 Million USD | 12.96% |
| 2021 Q1 | 126.49 Million USD | 0.45% |
| 2021 Q2 | 123.68 Million USD | -2.22% |
| 2021 Q4 | 142.25 Million USD | 3.44% |
| 2020 Q4 | 125.92 Million USD | -7.98% |
| 2020 Q2 | 138.65 Million USD | -1.67% |
| 2020 Q1 | 141.01 Million USD | 4.94% |
| 2020 Q3 | 136.85 Million USD | -1.3% |
| 2020 FY | 125.92 Million USD | -6.28% |
| 2019 Q2 | 131.25 Million USD | 1.56% |
| 2019 FY | 134.37 Million USD | 11.22% |
| 2019 Q4 | 134.37 Million USD | -1.4% |
| 2019 Q3 | 136.27 Million USD | 3.83% |
| 2019 Q1 | 129.23 Million USD | 6.96% |
| 2018 Q2 | 119.49 Million USD | 1.54% |
| 2018 Q1 | 117.68 Million USD | 8.42% |
| 2018 FY | 120.82 Million USD | 11.32% |
| 2018 Q4 | 120.82 Million USD | -2.9% |
| 2018 Q3 | 124.43 Million USD | 4.13% |
| 2017 Q1 | 113.42 Million USD | 7.96% |
| 2017 Q4 | 108.54 Million USD | -6.35% |
| 2017 FY | 108.54 Million USD | 3.32% |
| 2017 Q3 | 115.9 Million USD | 1.84% |
| 2017 Q2 | 113.8 Million USD | 0.34% |
| 2016 Q1 | 117.35 Million USD | 1.18% |
| 2016 Q4 | 105.05 Million USD | -9.88% |
| 2016 FY | 105.05 Million USD | -9.43% |
| 2016 Q3 | 116.57 Million USD | -0.28% |
| 2016 Q2 | 116.9 Million USD | -0.39% |
| 2015 FY | 115.98 Million USD | 9.27% |
| 2015 Q4 | 115.98 Million USD | -0.97% |
| 2015 Q3 | 117.12 Million USD | 5.03% |
| 2015 Q2 | 111.51 Million USD | -2.01% |
| 2015 Q1 | 113.79 Million USD | 7.2% |
| 2014 Q1 | 99.99 Million USD | 13.95% |
| 2014 Q2 | 104.49 Million USD | 4.5% |
| 2014 Q4 | 106.15 Million USD | -3.24% |
| 2014 Q3 | 109.7 Million USD | 4.99% |
| 2014 FY | 106.15 Million USD | 20.97% |
| 2013 Q2 | 88.15 Million USD | 0.19% |
| 2013 Q3 | 95.08 Million USD | 7.87% |
| 2013 Q4 | 87.75 Million USD | -7.71% |
| 2013 FY | 87.75 Million USD | 7.55% |
| 2013 Q1 | 87.98 Million USD | 7.84% |
| 2012 Q4 | 81.59 Million USD | -11.53% |
| 2012 FY | 81.59 Million USD | 0.0% |
| 2012 Q2 | 88.83 Million USD | 0.0% |
| 2012 Q3 | 92.22 Million USD | 3.82% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Phreesia, Inc. | - USD | -Infinity% |
| Align Technology, Inc. | 296.9 Million USD | 53.411% |
| Elevance Health Inc. | -46.33 Billion USD | 100.299% |
| AxoGen, Inc. | 23.02 Million USD | -500.886% |
| Boston Scientific Corporation | 2.48 Billion USD | 94.431% |
| CVS Health Corporation | 18.02 Billion USD | 99.233% |
| Cardinal Health, Inc. | 14.95 Billion USD | 99.075% |
| Centene Corporation | - USD | -Infinity% |
| DaVita Inc. | 143.1 Million USD | 3.341% |
| HCA Healthcare, Inc. | 2.02 Billion USD | 93.156% |
| Hologic, Inc. | 679.8 Million USD | 79.652% |
| Humana Inc. | - USD | -Infinity% |
| IDEXX Laboratories, Inc. | 380.28 Million USD | 63.626% |
| Laboratory Corporation of America Holdings | 474.6 Million USD | 70.855% |
| Masimo Corporation | 545 Million USD | 74.619% |
| McKesson Corporation | 21.13 Billion USD | 99.346% |
| Patterson Companies, Inc. | 782.89 Million USD | 82.332% |
| Quest Diagnostics Incorporated | 190 Million USD | 27.198% |
| ResMed Inc. | 822.25 Million USD | 83.177% |
| Henry Schein, Inc. | 1.81 Billion USD | 92.379% |
| Teladoc Health, Inc. | 29.51 Million USD | -368.688% |
| Universal Health Services, Inc. | 216.98 Million USD | 36.253% |
| Veeva Systems Inc. | - USD | -Infinity% |
| Baxter International Inc. | 2.82 Billion USD | 95.102% |
| Becton, Dickinson and Company | 3.27 Billion USD | 95.774% |
| Intuitive Surgical, Inc. | 1.22 Billion USD | 88.668% |
| Danaher Corporation | 2.59 Billion USD | 94.668% |
| Stryker Corporation | 4.84 Billion USD | 97.144% |
| Medtronic plc | 5.21 Billion USD | 97.349% |